Inactive Instrument

News Advanced Medical Isotope Corp. Other OTC

Equities

US00765X1028

End-of-day quote Other OTC Other stock markets
- ^USD	-

Mar. 18	Vivos Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Vivos Inc. Announces Radiogel(TM) Precision Radionuclide Therapy(TM) Receives FDA Breakthrough Device Designation	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Vivos Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 18	CI
Radiogel™ Precision Radionuclide Therapy™ Receives FDA Breakthrough Device Designation	Dec. 20	AQ
Vivos Inc. Announces Radiogel(TM) Precision Radionuclide Therapy(TM) Receives FDA Breakthrough Device Designation	Dec. 20	CI
Vivos Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 06	CI
Vivos : Quarterly Progress Report - Form 8-K	23-10-11	PU
Vivos Inc. Announces Certification of Three New IsoPet® Precision Radionuclide Therapy Regional Clinics	23-08-07	AQ
Vivos Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-04	CI
VIVOS INC Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	23-05-04	AQ
Vivos Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-04	CI
VIVOS INC : Unregistered Sale of Equity Securities (form 8-K)	23-05-02	AQ
VIVOS INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-K)	23-03-01	AQ
Vivos Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-01	CI
Vivos Inc. Auditor Raises 'Going Concern' Doubt	23-02-28	CI
Vivos Inc Files a New Patent on Alternate Particles for Precision Radionuclide Therapy	23-01-11	AQ
Vivos Inc Files A New Patent on Alternate Particles for Precision Radionuclide Therapy	23-01-11	CI
Vivos Inc Files a New Patent on Precision Radionuclide Therapy Support System Equipment	23-01-03	AQ
Vivos Inc. Files New Patent on Precision Radionuclide Therapy Support System Equipment	23-01-03	CI
VIVOS INC Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	22-10-19	AQ
Vivos Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-10-19	CI
Vivos Inc Files a New Patent on the Hydrogel Component of IsoPet®/RadioGel™	22-09-14	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Advanced Medical Isotope Corp. Other OTC

Equities

US00765X1028

Summary

Filters